生物可吸收支架市場規模、佔有率、成長分析（按產品類型、吸收率、應用、地區分類）- 產業預測，2025 年至 2032 年

2023 年生物可吸收支架市場規模價值 25.6 億美元，預計將從 2024 年的 27.9 億美元成長到 2032 年的 55.1 億美元，預測期內（2025-2032 年）的複合年成長率為 8.9%。

受人口老化和心血管疾病發病率上升的推動，全球生物可吸收支架市場預計將顯著成長。冠狀動脈疾病的增加導致經經皮冠狀動脈介入治療 (PCI) 手術的增加以及患者和醫療保健提供者對生物可吸收支架的採用增加。技術進步和向微創治療的轉變進一步推動了市場擴張。促進創新的發展措施和有利的法規正在促進生物可吸收支架的發展。然而，手術成本高以及與這些支架相關的潛在風險等挑戰可能會阻礙其成長。總體而言，人口變化、技術進步和政府支持措施將在塑造市場未來發展軌跡方面發揮關鍵作用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局

生物可吸收支架市場規模（依產品類型）

• 市場概況
• 聚合物基生物可吸收支架
• 金屬基生物可吸收支架

生物可吸收支架市場規模（依吸收率）

• 市場概況
• 慢吸收支架
• 快速吸收支架

生物可吸收支架市場規模（依聚合物基生物可吸收支架分類）

• 市場概況
• 聚乳酸-乙醇酸支架
• Polyglycolic支架
• 聚（L-乳酸）支架
• 其他生物分解性聚合物支架

生物可吸收支架市場規模（依金屬基生物可吸收支架分類）

• 市場概況
• 鎂基支架
• 鐵基支架
• 鋅基支架
• 其他金屬基生物可吸收支架

生物可吸收支架市場規模（依應用）

• 市場概況
• 冠狀動脈疾病
• 周邊動脈疾病

生物可吸收支架市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Boston Scientific Corporation（USA）
• Arterius Limited（UK）
• Kyoto Medical Planning Co., Ltd.（Japan）
• Terumo Corporation（Japan）
• Elixir Medical Corporation（USA）
• Abbott Laboratories Inc.（USA）
• Amaranth Medical（USA）
• Biotronik（Germany）
• Meril Life Sciences Pvt. Ltd.（India）
• Reva Medical（USA）
• Svelte Medical Systems（USA）
• Lepu Medical Technology Co., Ltd.（China）
• Medtronic plc（Ireland）
• B. Braun Melsungen AG（Germany）
• MicroPort Scientific Corporation（China）
• Cardionovum GmbH（Germany）
• Biotronik SE & Co. KG（Germany）
• ICON Interventional Systems（USA）
• Arterial Remodeling Technologies（France）
• Elixir Medical Corporation（USA）

結論和建議

Bioabsorbable Stents Market size was valued at USD 2.56 billion in 2023 and is poised to grow from USD 2.79 billion in 2024 to USD 5.51 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The global bioabsorbable stents market is poised for significant growth driven by an aging population and escalating cardiovascular disease prevalence. The rise in coronary artery disease has led to an uptick in percutaneous coronary intervention (PCI) procedures, amplifying the adoption of bioabsorbable stents by both patients and healthcare providers. Technological advancements and a shift towards minimally invasive treatments further boost market expansion. Government initiatives promoting innovation and favorable regulations enhance the development of bioabsorbable stents. However, challenges such as the high cost of procedures and potential risks associated with these stents could impede growth. Overall, demographic shifts, technological progress, and supportive government measures will play crucial roles in shaping the market's future trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioabsorbable Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioabsorbable Stents Market Segments Analysis

Global Bioabsorbable Stents Market is segmented by Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application and region. Based on Product Type, the market is segmented into Polymer-Based Bioabsorbable Stents and Metal-Based Bioabsorbable Stents. Based on Absorption Rate, the market is segmented into Slow-Absorption Stents and Fast-Absorption Stents. Based on Polymer-Based Bioabsorbable Stents, the market is segmented into PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly (L-Lactic Acid)) Stents and Other Biodegradable Polymer Stents. Based on Metal-Based Bioabsorbable Stents, the market is segmented into Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents and Other Metal-Based Bioabsorbable Stents. Based on Application, the market is segmented into Coronary Artery Diseases and Peripheral Artery Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioabsorbable Stents Market

The Bioabsorbable Stents market is significantly driven by advancements in design and technology, which have accelerated the treatment of coronary artery disease with biodegradable stents. These innovative stents are crafted from biodegradable polymers that safely dissolve after fulfilling their purpose, enhancing patient outcomes. Research by the U.S. FDA has highlighted the potential of these stents to mitigate late-stage complications, such as stent thrombosis. As a result, there is an increased patient acceptance and utilization, fostering wider market adoption and positioning bioabsorbable stents as a promising solution in cardiovascular care, effectively addressing a critical healthcare need for safer and more effective treatments.

Restraints in the Bioabsorbable Stents Market

The bioabsorbable stents market faces significant challenges due to concerns surrounding the long-term efficacy and safety of these devices. Healthcare providers remain skeptical, particularly following complications linked to several first-generation models, such as late stent thrombosis and restenosis, which have cast doubts on their clinical performance. These issues have negatively impacted market confidence, leading clinicians to advocate for more extensive clinical trials and the development of improved device designs. To regain trust in bioabsorbable stent technology, it is essential to establish enhanced safety profiles and provide comprehensive long-term data demonstrating their reliability and effectiveness in patient care.

Market Trends of the Bioabsorbable Stents Market

The bioabsorbable stents market is experiencing a significant trend towards the development of innovative materials aimed at enhancing clinical outcomes. Researchers are focusing on creating advanced composite materials that provide superior biocompatibility, increased mechanical strength, and optimized degradation rates. These improvements are designed to address the limitations of existing stent materials, ultimately leading to better patient outcomes and performance. This market shift highlights a commitment to enhancing the durability and long-term efficacy of bioabsorbable stents, thereby minimizing complications and bolstering the overall efficacy of cardiac interventions. As a result, growth in this segment is expected to accelerate significantly in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Bioabsorbable Stents Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Polymer-Based Bioabsorbable Stents
• Metal-Based Bioabsorbable Stents

Global Bioabsorbable Stents Market Size by Absorption Rate & CAGR (2025-2032)

• Market Overview
• Slow-Absorption Stents
• Fast-Absorption Stents

Global Bioabsorbable Stents Market Size by Polymer-Based Bioabsorbable Stents & CAGR (2025-2032)

• Market Overview
• PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents
• PGA (Polyglycolic Acid) Stents
• PLLA (Poly (L-Lactic Acid)) Stents
• Other Biodegradable Polymer Stents

Global Bioabsorbable Stents Market Size by Metal-Based Bioabsorbable Stents & CAGR (2025-2032)

• Market Overview
• Magnesium-Based Stents
• Iron-Based Stents
• Zinc-Based Stents
• Other Metal-Based Bioabsorbable Stents

Global Bioabsorbable Stents Market Size by Application & CAGR (2025-2032)

• Market Overview
• Coronary Artery Diseases
• Peripheral Artery Diseases

Global Bioabsorbable Stents Market Size & CAGR (2025-2032)

• North America (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • US
  • Canada
• Europe (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterius Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Medical Planning Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amaranth Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reva Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Svelte Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Interventional Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterial Remodeling Technologies (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations